Catheter Ablation of Long Standing Persistent Atrial Fibrillation: Lessons Learned

Journal of Atrial Fibrillation
Obiora Anusionwu, Hugh Calkins

Abstract

Atrial fibrillation has evolved from being a novel unproven procedure to being an important treatment option for patients with symptomatic atrial fibrillation. Atrial fibrillation ablation is an appropriate treatment option for patients with symptomatic atrial fibrillation, particularly if they have failed one or more trials of antiarrhythmic drug therapy. While much has been learned about the optimal technique and outcomes for catheter ablation of paroxysmal atrial fibrillation; catheter ablation of atrial fibrillation in patients with long standing persistent atrial fibrillation remains in its infancy. The following objectives would be accomplished in this review article. First, we will review the various ablation strategies, which have been employed and proposed for ablation of long standing persistent atrial fibrillation. Second, the methodology, results and outcomes of the major studies were reviewed in detail, which have reported outcomes of ablation in this patient population. And finally, some conclusions were drawn regarding where we stand and where the knowledge gaps remain as we seek to improve ablation outcomes in this population of AF patients.

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Related Papers

JAMA : the Journal of the American Medical Association
Uma N Srivatsa
JAMA : the Journal of the American Medical Association
Federico Viganego
JAMA : the Journal of the American Medical Association
Hakan Paydak, Jawahar L Mehta
The New England Journal of Medicine
Jens Cosedis NielsenPeter Steen Hansen
© 2022 Meta ULC. All rights reserved